PATH EX, Inc. Announces Successful $5 Million Financing Round to Advance CycloPE, a Breakthrough Treatment for Sepsis.
Get access to detailed funding analysis, investor insights, company intelligence, and much more
Round size percentiles, market activity, sector trends
Growth stage analysis, funding history, investor quality
Export data, save to watchlist, share analysis
Join thousands of investors, founders, and analysts who rely on Seedtable's intelligence platform